There are few data on the use of highly active antiretroviral therapy in HIV-positive patients with end-stage renal disease. We describe the tolerability, safety and efficacy of an efavirenz-containing regimen in one such patient on continuous ambulatory peritoneal dialysis.
View Article and Find Full Text PDF